Shareholding disclosure

Deutsche Bank AG

Declared position

Threshold

Fell below threshold

Timeline

Published

14.07.2020

Transaction

07.07.2020

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK7A00039

Beneficial owner

Deutsche Bank AG

Declared address

DEUTSCHE BANK AKTIENGESELLSCHAFT, 60325 Frankfurt am Main

Equity collateral returned via transfer of title.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Deutsche Bank AG

Vifor Pharma AG14.07.2020TAK7A00039

Disclosure summary

Deutsche Bank AG disclosed a holding in Vifor Pharma AG that fell below the publication threshold, published by SIX Exchange Regulation on 14.07.2020, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Deutsche Bank AG disclosed a holding in Vifor Pharma AG, published on 14.07.2020.

Publication date14.07.2020

Transaction date07.07.2020

Issuing companyVifor Pharma AG

Beneficial ownerDeutsche Bank AG

Declared addressDEUTSCHE BANK AKTIENGESELLSCHAFT, 60325 Frankfurt am Main

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAK7A00039

Conditions

Equity collateral returned via transfer of title.

Source: SIX Exchange Regulation · Publication date: 14.07.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open